Kuwana, Masataka

Nintedanib for systemic sclerosis–associated interstitial lung disease

Distler, O., Highland, K. B., Gahlemann, M., Azuma, A., Fischer, A., Mayes, M. D., Raghu, G., Sauter, W., Girard, M., Alves, M., et al. (2019) · New England Journal of Medicine

Systemic Sclerosis and Related DiseasesInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Cited by 1,647

Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype

Inoue, Y., Kaner, R. J., Guiot, J., Maher, T. M., Tomassetti, S., Moiseev, S., Kuwana, M., & Brown, K. K. (2020) · Chest

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisSystemic Sclerosis and Related Diseases

Cited by 133

Tocilizumab is effective against polymyalgia rheumatica: experience in 13 intractable cases

Izumi, K., Kuda, H., Ushikubo, M., Kuwana, M., Takeuchi, T., & Oshima, H. (2015) · RMD Open

Vasculitis and related conditionsRheumatoid Arthritis Research and Therapies

Cited by 31